Zacks Research Analysts Raise Earnings Estimates for Integer

Integer Holdings Co. (NYSE:ITGR) – Equities researchers at Zacks Research increased their Q4 2024 earnings estimates for Integer in a research note issued to investors on Tuesday, January 7th. Zacks Research analyst D. Dey now expects that the medical equipment provider will earn $1.46 per share for the quarter, up from their previous estimate of $1.45. The consensus estimate for Integer’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer’s Q3 2026 earnings at $1.65 EPS.

A number of other equities analysts have also recently weighed in on ITGR. Citigroup raised their price objective on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a report on Wednesday, December 11th. Truist Financial lifted their price target on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Piper Sandler restated an “overweight” rating and issued a $140.00 price objective (up from $125.00) on shares of Integer in a report on Friday, October 25th. KeyCorp increased their target price on shares of Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a report on Tuesday, October 15th. Finally, Benchmark upped their price target on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, October 21st. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $145.44.

Integer Trading Up 0.7 %

NYSE ITGR opened at $133.13 on Friday. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The stock’s 50-day simple moving average is $135.73 and its two-hundred day simple moving average is $127.72. Integer has a twelve month low of $94.56 and a twelve month high of $142.76. The company has a market capitalization of $4.47 billion, a price-to-earnings ratio of 41.09, a PEG ratio of 1.99 and a beta of 1.12.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The firm had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. During the same quarter in the prior year, the firm earned $1.27 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year.

Hedge Funds Weigh In On Integer

Hedge funds have recently made changes to their positions in the business. Loomis Sayles & Co. L P boosted its holdings in Integer by 3.0% in the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock valued at $69,943,000 after acquiring an additional 15,446 shares in the last quarter. Jane Street Group LLC boosted its stake in shares of Integer by 23.3% during the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after purchasing an additional 28,572 shares in the last quarter. Earnest Partners LLC increased its position in shares of Integer by 3.2% during the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after buying an additional 37,340 shares during the period. Verition Fund Management LLC raised its stake in Integer by 17.4% in the third quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider’s stock worth $451,000 after buying an additional 515 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new stake in Integer in the third quarter worth about $651,000. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.